Urgent need of establishment of new animal models of retinopathy of prematurity

( views:135, downloads:0 )
WANG Yu-Sheng(Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China)
CHU Zhao-Jie(Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China)
Journal Title:
Chinese Journal of Ocular Fundus Diseases
Volume 28, Issue 01, 2012
Key Word:
Retinopathy of prematurity;Disease Models, animal;Editorial

Abstract: The etiological factors and pathogenesis of retinopathy of prematurity (ROP) are still unclear,which restricted its effective prevention and treatment.The current animal model widely used in ROP investigation is oxygen-induced retinopathy model,which is lack of specificity,and does not mimic the real pathogenesis status of human ROP patients.Thus,we should refresh our concept,seek breakthroughs in multi-disciplines,integrate more risk factors of ROP,utilize the rising technique in transgenic animal,and improve the evaluation system for improving the current models or explore new animal models of ROP.It is important for prevention and treatment of ROP.

  • [1]Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle-income countries.Lancet,1997,350:12-14.
  • [2]Maida JM,Mathers K,Alley CL.Pediatric ophthalmology in the developing world.Curr Opin Ophthalmol,2008,19:403-408.
  • [3]黎晓新.我国早产儿视网膜病变特点和筛查指南.中华眼底病杂志,2004,20:384-386.
  • [4]王雨生,李蓉.重视我国早产儿视网膜病变的防治工作.中华眼科杂志,2011,47:483-486.
  • [5]吉桂芳,徐洪妹,沈红芬.上海市盲校学生病因及视力调查分析.眼科新进展,2006,26:622-623.
  • [6]刘斌,黄文勇,何明光,等.广州市盲校学生致盲及低视力原因调查.眼科学报,2007,23:117-120.
  • [7]Chen Y,Li XX,Yin H,et al.Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing,China.Br J Ophthalmol,2008,92:326-330.
  • [8]Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3 + retinopathy of prematurity.N EnglJ Med,2011,364:603-615.
  • [9]Palmer EA. Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP). Doc Ophthalmol,1990,74:245-251.
  • [10]Early Treatment for Retinopathy of Prematurity Cooperative Group.Revised indications for the treatment of retinopathy of prematurity:results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol,2003,121:1684-1694.
  • [11]Ashton N,Ward B,Serpell G.Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia.Br J Ophthalmol,1954,38:397-432.
  • [12]Patz A.Clinical and experimental studies on role of oxygen in retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol,1954,58:45-50.
  • [13]Gyllensten LJ,Hellstrom BE. Experimental approach to the pathogenesis of retrolental fibroplasia. I. Changes of the eye induced by exposure of newborn mice to concentrated oxygen.Acta Pediatr Suppl,1954,43:131-148.
  • [14]Patz A.Oxygen studies in retrolental fibroplasia. Ⅳ.Clinical and experimental observations. Am J Ophthalmol,1954,38:291-308.
  • [15]Smith LE,Wesolowski E,McLellan A,et al.Oxygen-induced retinopathy in the mouse.Invest Ophthalmol Vis Sci,1994,35:101-111.
  • [16]Penn JS,Tolman BL,Lowery LA.Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci,1993,34:576-585.
  • [17]单海冬,赵培泉.早产儿视网膜病变的动物模型.中华眼底病杂志,2005,21:340-343.
  • [18]Holmes JM,Zhang S,Leske DA,et al.Carbon dioxide-induced retinopathy in the neonatal rat.Curr Eye Res,1998,17:608-616.
  • [19]Holmes JM,Zhang S,Leske DA,et al. Metabolic acidosisinduced retinopathy in the neonatal rat.Invest Ophthalmol Vis Sci,1999,40:804-809.
  • [20]Grossniklaus HE, Kang SJ, Berglin L. Animal models of choroidal and retinal neovascularization.Prog Retin Eye Res,2010,29:500-519.
  • [21]Connor KM,Krah NM,Dennison RJ,et al.Quantification of oxygen-induced retinopathy in the mouse:a model of vessel loss,vessel regrowth and pathological angiogenesis. Nat Protoc,2009,4:1565-1573.
  • [22]Stahl A, Connor KM, Sapieha P, et al. Computer-aided quantification of retinal neovascularization.Angiogenesis,2009,12:297-301.
  • [23]Fergusson D,Hébert PC,Lee SK,et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA,2003,289:1950-1956.
  • [24]Holmstrom G,van Wijngaarder P,Coster DJ,et al.Genetic susceptibility to retinopathy of prematurity:the evidence from clinical and experimental animal studies. Br J Ophthalmol,2007,91:1704-1708.
  • [25]Dorfman AL,Polosa A,Joly S,et al.Functional and structural changes resulting from strain differences in the rat model of oxygen-induced retinopathy.Invest Ophthalmol Vis Sci,2009,50:2436-2450.
  • [26]van Wijngaarder P,Brereton HM,Coster DJ,et al.Hereditary influences in oxygen-induced retinopathy in the rat. Doc Ophthalmol,2010,120:87-97.
  • [27]Okamoto N,Tobe T,Hackett SF,et al.Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.Am J Pathol,1997,151:281-291.
  • [28]Ohno-Matsui K, Hirose A, Yamamoto S, et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.Am J Pathol,2002,160:711-719.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn